Chronic Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Decreases Hypertension, Insulin Resistance, and Hypertriglyceridemia in Metabolic Syndrome

Metabolic syndrome is a constellation of risk factors including hypertension, dyslipidemia, insulin resistance, and obesity that promote the development of cardiovascular disease. Metabolic syndrome has been associated with changes in the secretion or metabolism of glucocorticoids, which have import...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schnackenberg, Christine G., Costell, Melissa H., Krosky, Daniel J., Cui, Jianqi, Wu, Charlene W., Hong, Victor S., Harpel, Mark R., Willette, Robert N., Yue, Tian-Li
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3613092/
https://ncbi.nlm.nih.gov/pubmed/23586038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/427640
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados